Anti-MMP25/ MMP-25/ MMP20 monoclonal antibody
Anti-MMP25/ MMP-25/ MMP20 antibody for FACS & in-vivo assay
Go to MMP25/MMP25 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0820-Ab-1/ GM-Tg-hg-MP0820-Ab-2 | Anti-Human MMP25 monoclonal antibody | Human |
GM-Tg-rg-MP0820-Ab-1/ GM-Tg-rg-MP0820-Ab-2 | Anti-Rat MMP25 monoclonal antibody | Rat |
GM-Tg-mg-MP0820-Ab-1/ GM-Tg-mg-MP0820-Ab-2 | Anti-Mouse MMP25 monoclonal antibody | Mouse |
GM-Tg-cynog-MP0820-Ab-1/ GM-Tg-cynog-MP0820-Ab-2 | Anti-Cynomolgus/ Rhesus macaque MMP25 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0820-Ab-1/ GM-Tg-felg-MP0820-Ab-2 | Anti-Feline MMP25 monoclonal antibody | Feline |
GM-Tg-cang-MP0820-Ab-1/ GM-Tg-cang-MP0820-Ab-2 | Anti-Canine MMP25 monoclonal antibody | Canine |
GM-Tg-bovg-MP0820-Ab-1/ GM-Tg-bovg-MP0820-Ab-2 | Anti-Bovine MMP25 monoclonal antibody | Bovine |
GM-Tg-equg-MP0820-Ab-1/ GM-Tg-equg-MP0820-Ab-2 | Anti-Equine MMP25 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0820-Ab-1/ GM-Tg-hg-MP0820-Ab-2; GM-Tg-rg-MP0820-Ab-1/ GM-Tg-rg-MP0820-Ab-2; GM-Tg-mg-MP0820-Ab-1/ GM-Tg-mg-MP0820-Ab-2; GM-Tg-cynog-MP0820-Ab-1/ GM-Tg-cynog-MP0820-Ab-2; GM-Tg-felg-MP0820-Ab-1/ GM-Tg-felg-MP0820-Ab-2; GM-Tg-cang-MP0820-Ab-1/ GM-Tg-cang-MP0820-Ab-2; GM-Tg-bovg-MP0820-Ab-1/ GM-Tg-bovg-MP0820-Ab-2; GM-Tg-equg-MP0820-Ab-1/ GM-Tg-equg-MP0820-Ab-2 |
Products Name | Anti-MMP25 monoclonal antibody |
Format | mab |
Target Name | MMP25 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-MMP25 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species MMP25/ MMP-25/ MMP20 VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP0820 |
Target Name | MMP25 |
Gene ID | 64386,240047,302963,700486,490046,101097941,531092,100068942 |
Gene Symbol and Synonyms | F730048C11Rik,Leukolysin,MMP-25,MMP20,MMP20A,MMP25,MMPL1,MT-MMP 6,MT-MMP6,MT6-MMP,MT6MMP,M™MP6 |
Uniprot Accession | Q9NPA2 |
Uniprot Entry Name | MMP25_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000008516 |
Target Classification | N/A |
The target: MMP25, gene name: MMP25, also named as MMP-25, MMP20, MMP20A, MMPL1, MT-MMP 6, MT-MMP6, MT6-MMP, MT6MMP, M™MP6. Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMPs are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. However, the protein encoded by this gene is a member of the membrane-type MMP (MT-MMP) subfamily, attached to the plasma membrane via a glycosylphosphatidyl inositol anchor. In response to bacterial infection or inflammation, the encoded protein is thought to inactivate alpha-1 proteinase inhibitor, a major tissue protectant against proteolytic enzymes released by activated neutrophils, facilitating the transendothelial migration of neutrophils to inflammatory sites. The encoded protein may also play a role in tumor invasion and metastasis through activation of MMP2. The gene has previously been referred to as MMP20 but has been renamed MMP25. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.